UK: SABMiller gives chairman medical leave of absence
Graham Mackay had surgery for a brain tumour in April
SABMiller has granted its chairman a "medical leave of absence" while he recovers from surgery for a brain tumour.
Graham Mackay was diagnosed with the tumour in April and replaced immediately as the group's CEO by Alan Clark. The planned switch was due to happen next month.
John Manser, the group's deputy chairman was installed as acting chairman following news of Mackay's illness. Manser will continue in the role "for the time being", SABMiller said today (6 June).
"The board will keep the position under review as Mr Mackay's treatment progresses, and an appropriate announcement about the future will be made as soon as any definitive decisions have been taken," the company said in a filing to the London Stock Exchange.
Manser has stood down as chairman of the group's audit committee today, a year earlier than originally planned, and retired from the audit and remuneration committees. Mark Armour has replaced Manser as audit committee chairman.
- Can craft breweries compete in lager arena?
- Wine consumption and its health effects
- The Coca-Cola Co's Q2/H1 2016 results - Preview
- A Wild Geese, Pernod Ricard conspiracy theory?
- Remy Cointreau's Q1 performance by brand, region
- Diageo names new TR head as Doug Bagley exits
- AB InBev seeks single buyer for European beers
- Diageo appoints new Smirnoff head
- Gruppo Campari trials Negroni pre-mix
- Scotch drop hits Edrington as FY profits fall
- Global RTD insights - market forecasts, product innovation and consumer trends
- Adultifying Soft Drinks; Capitalizing on rising adult demand for non-alcoholic beverages
- Global non-Scotch whiskies insights - market forecasts, product innovation and consumer trends
- Global Scotch whisky insights - market forecasts, product innovation and consumer trends
- Global travel retail insights - market forecasts, product innovation and consumer trends